Serum Endostatin Levels and Regenerative Capacities of Normal and Cirrhotic Livers Following Partial Hepatectomy in Mice: The Response to Different Resection Sizes

Journal of Surgical Research

Volumn 143, Issue 2, 2007, Pages 337-343

  Colakoglu, Tamer ^a   Keskek, Mehmet ^a   Colakoglu, Sule ^a   Can, Bilge ^a   Sayek, Iskender ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

angiogenesis; cirrhosis; endostatin; hepatectomy; liver regeneration

Indexed keywords

CARBON TETRACHLORIDE; CYCLINE; ENDOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; LIVER CIRRHOSIS; LIVER REGENERATION; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL;

ANIMALS; ENDOSTATINS; FEMALE; HEPATECTOMY; LIVER CIRRHOSIS; LIVER REGENERATION; MICE; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 36049040656     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.02.001     Document Type: Article

References (35)

1. Higgins G.M., and Anderson R.M. Experimental pathology of the liver: Restoration of the liver of white rat following partial surgical removal. Arch Pathol 12 (1931) 186
2. Andiran F., Ayhan A., Tanyel F.C., et al. Regenerative capacities of normal and cirrhotic livers following 70% hepatectomy in rats and the effect of α-Tocopherol on cirrhotic regeneration. J Surg Res 89 (2000) 184
3. de Jong K.P., Slooff M.J.H., de Vries E.G.E., et al. Effect of partial liver resection on tumor growth. J Hepatol 25 (1996) 109
4. Picardo A., Karpoff H.M., Ng B., et al. Partial hepatectomy accelerates local tumor growth: Potential roles of local cytokine activation. Surgery 124 (1998) 57
5. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med 285 (1971) 1182
6. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 (1996) 353
7. O'Reilly M.S., Boehm T., Shing Y., et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88 (1997) 277
8. Boehm T., Folkman J., Browder T., et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390 (1997) 404
9. Kisker O., Becker C.M., Prox D., et al. Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res 61 (2001) 7669
10. Graepler F., Verbeek B., Graeter T., et al. Combined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCC. Hepatology 41 (2005) 879
11. te Velde E.A., Reijerkerk A., Brandsma D., et al. Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells. Br J Cancer 92 (2005) 729
12. Herbst R.S., Hess K.R., Tran H.T., et al. Phase I study of recombinant human endostatin in patients with advanced solid tumors. J Clin Oncol 20 (2002) 3792
13. Yamaguchi N., Anand-Apte B., Lee M., et al. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J 18 (1999) 4414
14. Sasaki T., Hohenester E., and Timpl R. Structure and function of collagen-derived endostatin inhibitors of angiogenesis. IUBMB Life 53 (2002) 77
15. Sasaki T., Fukai N., Mann K., et al. Structure, function, and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J 17 (1998) 4249
16. Lietard J., Theret N., Rehn M., et al. The promoter of the long variant of collagen XVIII, the precursor of endostatin, contains liver-specific regulatory elements. Hepatology 32 (2000) 1377
17. Musso O., Theret N., Heljasvaara R., et al. Tumor hepatocytes and basement membrane-producing cells specifically express two different forms of the endostatin precursor, collagen XVIII, in human liver cancer cells. Hepatology 33 (2001) 868
18. Uematsu S., Higashi T., Nouso K., et al. Altered expression of vascular endothelial growth factor, fibroblast growth factor-2, and endostatin in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 20 (2005) 583
19. Espat N.J., Auffenberg T., Abouhamze A., et al. A role for tumor necrosis factor-α in the increased mortality associated with Vibrio vulnificus injection in the presence of hepatic dysfunction. Ann Surg 223 (1996) 428
20. Rozga J. Animal models of liver regeneration. In: Souba W.W., and Wilmore D.W. (Eds). Surgical Research (2001), Academic Press, California 703
21. Assy N., and Minuk G.Y. Liver regeneration: Methods for monitoring and their applications. J Hepatol 26 (1997) 945
22. Kahn D., Hickman R., Terblanche J., et al. Partial hepatectomy and liver regeneration in pigs-the response to different resection sizes. J Surg Res 45 (1988) 176
23. Michalopoulos G.K., and DeFrances M.C. Liver regeneration. Science 276 (1997) 60
24. Drixler T.A., Vogten M.J., Ritchie E.D., et al. Liver regeneration is an angiogenesis associated phenomenon. Ann Surg 6 (2002) 703
25. Wack K.E., Ross M.A., Zegarra M., et al. Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver. Hepatology 33 (2001) 363
26. Ross M.A., Sander C.M., Kleeb T.B., et al. Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver. Hepatology 34 (2001) 1135
27. Ramanujan S., Koenig G.C., Padera T.P., et al. Local imbalance of proangiogenic and antiangiogenic factors: A potential mechanism of focal necrosis and dormancy in tumors. Cancer Res 60 (2000) 1442
28. Dhar D.K., Ono T., Yamanoi A., et al. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma. Cancer 95 (2002) 2188
29. Kraizer Y., Mawasi N., Seagal J., et al. Vascular endothelial growth factor and angiopoietin in liver regeneration. Biochem Biophys Res Commun 287 (2001) 209
30. Sato T., El-Assal O.N., Ono T., et al. Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver. J Hepatol 34 (2001) 690
31. Sim B.K. Angiostatin and Endostatin: Endothelial cell-specific endogenous inhibitors of angiogenesis and tumor growth. Angiogenesis 2 (1998) 37
32. Miyazaki S., Takasaki K., Yamamoto M., et al. Liver regeneration and restoration of liver function after partial hepatectomy: The relation of fibrosis of the liver parenchyma. Hepato-Gastroenterol 46 (1999) 2919
33. Delhaye M., Louis H., Degraef C., et al. Hepatocyte proliferative activity in human liver cirrhosis. J Hepatol 30 (1999) 461
34. Hashimoto M., and Watanabe G. Functional capacity of the cirrhotic liver after partial hepatectomy in the rat. Surgery 126 (1999) 541
35. Musso O., Rehn M., Saarela J., et al. Collagen XVIII is localized in sinusoids and basement membrane zones and expressed by hepatocytes and activated stellate cells in fibrotic human liver. Hepatology 28 (1998) 98